MIF and End Stage Liver Disease: As end-stage liver disease and hepatocarcinogenesis are associated with chronic intrahepatic and/or systemic inflammation, it is tempting to speculate that the pro-inflammatory effects of MIF, such as aggravating immune cell infiltration, might contribute to the increased incidence of complications such as decompensation or HCC development.